Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of OV101 in Individuals With Fragile X Syndrome (ROCKET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03697161
Recruitment Status : Completed
First Posted : October 5, 2018
Last Update Posted : May 11, 2020
Information provided by (Responsible Party):
Ovid Therapeutics Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 3, 2020
Actual Study Completion Date : February 26, 2020